AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2021

Dec 30, 2021

6965_dirs_2021-12-30_77c16f88-9ecb-4bb7-8045-a2a5b4ba4eea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2021-12-28

Reporting Person: KIDRON NADAV (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-28	Common Stock	F	31728	$12.98	Disposed	786481	Direct
2021-12-30	Common Stock	G	20000	—	Disposed	766481	Direct

Footnotes

F1: Payment of tax liability by withholding securities incident to the vesting of the issued security.

F2: This transaction represents a charitable donation effective December 30, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee.